[1] Hanifin JM,Reed ML.Eczema Prevalence and Impact Working Group.A population-based survey of eczema prevalence in the United States[J].Dermatitis,2007,18(2):82-91.
[2] Cardona ID,Cho SH,Leung DY.Role of bacterialsuperantigens in atopic dermatitis:implications for future therapeutic strategies[J].Am J Clin Dermatol,2006,7(5):273-279.
[3] Bieber T.Atopic dermatitis[J].N Engl J Med,2008,358(14):1483-1494.
[4] Biedermann T.Dissecting the role of infections in atopic dermatitis[J].Acta Derm Venereol,2006,86(2):99-109.
[5] Leung D.Superantigens,steroid insensitivity and innate immunity in atopic eczema[J].Acta Derm Venereol Suppl (Stockh),2005,(215):11-15.
[6] Leung DY.The role of Staphylococcus aureus in atopiceczema[J].Acta Derm Venereol,2008,Suppl 216:21-27.
[7] Eichenfield LF,Tom WL,Berger TG,et al.Guidelines of care for the management of atopic dermatitis:section 2.Management and treatment of atopic dermatitis with topical therapies[J].J Am Acad Dermatol,2014,71(1):116-132.
[8] Ring J,Alomar A,Bieber T,et al.Guidelines for treatment of atopic eczema (atopic dermatitis)part I[J].J Eur Acad Dermatol Venereol,2012,26(8):1045-1060.
[9] Katayama I,Kohno Y,Akiyama K,et al.Japanese guideline for atopic dermatitis 2014[J].Allergol Int,2014,63(3):377-398.
[10] 中华医学会皮肤性病学分会免疫学组.湿疹诊疗指南(2011年)[J].中华皮肤科杂志,2011,44(1):5-6.
[11] Crameri R,Garbani M,Rhyner C,et al.Fungi:the neglected allergenic sources[J].Allergy,2014,69(2):176-185.
[12] Grice EA,Segre JA.The skin microbiome[J].Nat RevMicrobiol,2011,9(4):244-253.
[13] 贾冬梅,佟训靓,罗庆录等.糖皮质激素对皮肤癣菌生长影响的研究[J].中国人兽共患病学报,2006,22(7):643-646.
[14] Kokjohn K,Bradley M,Griffiths B,et al.Evaluation of in vitro activity of ciclopirox olamine,butenafine HCl and econazole nitrate against dermatophytes,yeasts and bacteria[J].Int J Dermatol,2003,42(Suppl 1):11-17.
[15] Alsterholm M,Karami N,Faergemann J.Antimicrobial activity of topical skin pharmaceuticals-an in vitro study[J].Acta Derm Venereol,2010,90(3):239-245.
[16] Ikoma A.Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mechanisms and management of itch in atopic dermatitis[J].J Pharmacol Sci,2009,110(3):265-269.
[17] 郭静,李林峰,王云,等.硝酸益康唑/曲安奈德霜与丁酸氢化可的松软膏治疗亚急性慢性湿疹皮炎[J].临床皮肤科杂志,2002,31(2):108-109.
[18] 王继跃.派瑞松霜治疗湿疹疗效与抗菌作用的观察[J].医学信息,2010,23(9):141-142.
[19] 廖薇.硝酸益康唑/曲安奈德治疗手部慢性湿疹24例[J].医药导报,2003,22(2):106-107.
[20] 路雪艳,庞艳华,李邻峰.曲安奈德益康唑乳膏及糠酸莫米松乳膏对持续性局限性湿疹疗效及安全性的临床观察[J].中华临床医师杂志,2013,7(3):1097-1100.
[21] 余华峰.派瑞松治疗手部湿疹38例临床观察[J].中国社区医师医学专业,2011,13(17):61.
[22] 路雪艳,李邻峰.派瑞松乳膏在中国10年临床研究回顾[J].临床皮肤科杂志,2007,36(4):268-269.
[23] 赵辨.硝酸益康唑一曲安奈德乳膏治疗三种皮炎湿疹类疾病的疗效与安全性[J].中华皮肤科杂志,2005,38(6):399-400.
[24] Chowdhry PN,Gupta SL,Anand N.Diversity of fungi as human pathogen[J].Recent Research in Science and Technology,2013,5(1):17-20.
[25] Erbagci Z.Topical therapy for dermatophytoses:should corticosteroids be included[J]? Am J Clin Dermatol,2004,5(6):375-384.
|
